Skip to main content
DMII logo

DMII · Drugs Made In America Acquisition II Corp. · Financials

Track DMII — free
$10.17 -0.01 (-0.05%) At close · Sep 18
Market Cap
$647.19M
Shares
63.70M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
$4.19M
FY2025
Operating Cash Flow
-$1.02M
FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025
$635.24K $488.39K
$488.39K
-$635.24K -$488.39K
$4.93M
$4.68M
$13.02M $4.19M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
Peer median 67.36×

Peer medians compare against the 88 similar-size Shell Companies companies (of 136 listed).

Key facts CIK 2040475 CUSIP G2851K104 13F (30d) 2 filings 2 filers